申请人:Kowa Co., Ltd.
公开号:EP1403250A1
公开(公告)日:2004-03-31
Disclosed are bis(5-aryl-2-pyridyl) derivatives represented by the following formula (1) or salts thereof:
wherein A represents a substituted or unsubstituted aromatic hydrocarbon group or a substituted or unsubstituted aromatic heterocyclic group, and X represents a group selected from the following formulas (2) to (5):
wherein in the formula (2), m stands for an integer of 1 or 2; in the formula (3), n stands for an integer of 1 to 6; in the formula (4), R represents a hydrogen atom or a lower alkyl group and p stands for an integer of 1 to 6. Medicines, IgE antibody production inhibitors, medicinal compositions and treatment methods for allergic immune diseases, all of which make use of the bis(5-aryl-2-pyridyl) derivatives or salts thereof, are also disclosed.
本发明公开了由下式(1)代表的双(5-芳基-2-吡啶基)衍生物或其盐:
其中 A 代表取代或未取代的芳香烃基团或取代或未取代的芳香杂环基团,X 代表选自下式 (2) 至 (5) 的基团:
其中,在式 (2) 中,m 代表 1 或 2 的整数;在式 (3) 中,n 代表 1 至 6 的整数;在式 (4) 中,R 代表氢原子或低级烷基,p 代表 1 至 6 的整数。此外,还公开了利用双(5-芳基-2-吡啶基)衍生物或其盐的药物、IgE 抗体产生抑制剂、药物组合物和过敏性免疫疾病的治疗方法。